Media

mRNA-based vaccines have been one of the key elements in the fight against the coronavirus. The technology was originally developed for cancer therapy and can be used to treat many diseases. Together with partners from science and industry, Fraunhofer IPK is now researching how mRNA therapeutics and other medication can be better produced and more effectively applied.

The Fraunhofer IPK Project Office at Instituto Tecnológico de Aeronáutica (ITA) in São José dos Campos facilitates application-oriented research and development for the Brazilian manufacturing industry.

ÖKOTEC and Fraunhofer IPK are developing a high-performance digital networking platform to implement innovative efficiency approaches in companies within the new research and development project »EnEffNet«.

For a long time, there was no alternative to rigid production structures when fast throughput was required. Now they are becoming obsolete, as Fraunhofer IPK shows in its trend report. Instead of highly integrated, firmly linked lines, manufacturing experts increasingly favor modular production systems that can be flexibly combined.